Whole Exome Sequencing Market Research Report Information By Product (Kits, Systems, And Services), By Technology (Sequencing by Synthesis (SBS) And ION Semiconductor Sequencing), By Application (Diagnostics, Drug Discovery and development, And Agriculture and Animal Research), By End-User (Research Centers and Government Institutes, Hospitals and Diagnostics Centers And Pharmaceuticals & Biotechnology Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 17

1.1.1 MARKET SYNOPSIS 17

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 18

2.2 RESEARCH OBJECTIVE 18

2.3 LIST OF ASSUMPTIONS 19

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING USE OF EXOME SEQUENCING AND FUNDING PROGRAMS 30

4.2.2 COSTE-EFFECTIVE COMPARED TO OTHER SEQUENCING METHODS 30

4.2.3 INCREASING PRODUCT LAUNCHES BY MAJOR PLAYERS 30

4.2.4 DRIVERS IMPACT ANALYSIS 31

4.3 RESTRAINTS 32

4.3.1 UNFAVORABLE REGULATORY POLICIES 32

4.3.2 SOCIAL/ETHICAL/LEGAL ISSUES 32

4.3.3 RESTRAINTS IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 33

4.4.1 CLOUD-BASED TECHNOLOGY TO MANAGE THE DATABASE 33

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 34

5.1.1 THREAT OF NEW ENTRANTS 35

5.1.2 BARGAINING POWER OF SUPPLIERS 35

5.1.3 THREAT OF SUBSTITUTES 35

5.1.4 BARGAINING POWER OF BUYERS 35

5.1.5 INTENSITY OF RIVALRY 35

5.2 VALUE CHAIN ANALYSIS 36

5.2.1 R&D AND DESIGNING 37

5.2.2 MANUFACTURING 37

5.2.3 DISTRIBUTION 37

5.2.4 MARKETING & SALES 37

5.2.5 POST-SALES MONITORING 37

6 WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

6.1 INTRODUCTION 38

6.2 KITS 39

6.2.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 40

6.2.2 LIBRARY PREPARATION 40

6.2.3 TARGET ENRICHMENT 41

6.3 SEQUENCER 41

6.4 SERVICES 42

6.4.1 SEQUENCING SERVICES 42

6.4.2 DATA ANALYSIS (BIOINFORMATICS) 43

6.4.3 OTHERS 43

7 WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

7.1 INTRODUCTION 44

7.2 SEQUENCING BY SYNTHESIS (SBS) 45

7.3 ION SEMICONDUCTOR SEQUENCING 46

7.4 OTHERS 46

8 WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

8.1 INTRODUCTION 47

8.2 DIAGNOSTICS 48

8.2.1 CANCER DIAGNOSTICS 49

8.2.2 MONOGENIC (MENDELIAN) DISORDERS 50

8.2.3 MONOGENIC TYPES OF DIABETES 50

8.2.4 MOVEMENT DISORDERS 51

8.2.5 HIV 51

8.2.6 OTHERS 52

8.3 DRUG DISCOVERY AND DEVELOPMENT 52

8.4 AGRICULTURE AND ANIMAL RESEARCH 53

8.5 OTHERS 53

9 WHOLE EXOME SEQUENCING MARKET, BY END USER

9.1 INTRODUCTION 54

9.2 RESEARCH CENTERS AND GOVERNMENT INSTITUTES 55

9.3 HOSPITALS AND DIAGNOSTICS CENTERS 56

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 56

9.5 OTHERS 57

10 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION

10.1 INTRODUCTION 58

10.2 AMERICAS 60

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1 NORTH AMERICA 63

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1.1 US 66

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.1.2 CANADA 69

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.2.2 LATIN AMERICA 71

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3 EUROPE 74

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1 WESTERN EUROPE 77

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.1 GERMANY 80

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.2 FRANCE 83

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.3 UK 85

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.4 ITALY 88

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.5 SPAIN 90

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.1.6 REST OF WESTERN EUROPE 93

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.3.2 EASTERN EUROPE 95

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4 ASIA-PACIFIC 98

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.1 JAPAN 101

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.2 CHINA 104

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.3 INDIA 106

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.4 SOUTH KOREA 109

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.5 AUSTRALIA 111

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.4.6 REST OF ASIA-PACIFIC 114

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5 MIDDLE EAST & AFRICA 117

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5.1 MIDDLE EAST 120

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

10.5.2 AFRICA 123

WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

WHOLE EXOME SEQUENCING MARKET, BY END USER

11 COMPETITIVE LANDSCAPE: GLOBAL WHOLE EXOME SEQUENCING MARKET

11.1 OVERVIEW 126

11.2 COMPETITIVE ANALYSIS 126

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL WHOLE EXOME SEQUENCING MARKET 126

11.4 MARKET SHARE ANALYSIS 128

11.5 COMPETITIVE BENCHMARKING 129

11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 130

11.6.1 COLLABORATIONS & PARTNERSHIPS 130

11.6.2 EXPANSIONS 131

11.7 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 131

11.7.1 SALES AND OPERATING PROFIT MARGIN 131

11.7.2 R&D EXPENDITURE 132

12 COMPANY PROFILES

12.1 ILLUMINA INC. 133

12.1.1 COMPANY OVERVIEW 133

12.1.2 FINANCIAL OVERVIEW 134

12.1.3 PRODUCTS/SERVICES OFFERED 135

12.1.4 KEY DEVELOPMENTS 135

12.1.5 SWOT ANALYSIS 136

12.1.6 KEY STRATEGIES 136

12.2 BGI 137

12.2.1 COMPANY OVERVIEW 137

12.2.2 FINANCIAL OVERVIEW 138

12.2.3 PRODUCTS/SERVICES OFFERED 138

12.2.4 KEY DEVELOPMENTS 139

12.2.5 SWOT ANALYSIS 139

12.2.6 KEY STRATEGIES 139

12.3 EUROFINS SCIENTIFIC 140

12.3.1 COMPANY OVERVIEW 140

12.3.2 FINANCIAL OVERVIEW 140

12.3.3 PRODUCTS/SERVICES OFFERED 141

12.3.4 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS 141

12.3.5 SWOT ANALYSIS 142

12.3.6 KEY STRATEGIES 142

12.4 THERMO FISHER SCIENTIFIC 143

12.4.1 COMPANY OVERVIEW 143

12.4.2 FINANCIAL OVERVIEW 144

12.4.3 PRODUCTS/SERVICES OFFERED 145

12.4.4 KEY DEVELOPMENTS 145

12.4.5 SWOT ANALYSIS 146

12.4.6 KEY STRATEGIES 146

12.5 AGILENT TECHNOLOGIES, INC. 147

12.5.1 COMPANY OVERVIEW 147

12.5.2 FINANCIAL OVERVIEW 147

12.5.3 PRODUCTS/SERVICES OFFERED 148

12.5.4 KEY DEVELOPMENTS 148

12.5.5 SWOT ANALYSIS 149

12.5.6 KEY STRATEGIES 149

12.6 F. HOFFMANN-LA ROCHE LTD 150

12.6.1 COMPANY OVERVIEW 150

12.6.2 FINANCIAL OVERVIEW 151

12.6.3 PRODUCTS/SERVICES OFFERED 151

12.6.4 KEY DEVELOPMENTS 152

12.6.5 SWOT ANALYSIS 152

12.6.6 KEY STRATEGIES 152

12.7 GENEWIZ 153

12.7.1 COMPANY OVERVIEW 153

12.7.2 FINANCIAL OVERVIEW 154

12.7.3 PRODUCTS/SERVICES OFFERED 154

12.7.4 KEY DEVELOPMENTS 155

12.7.5 SWOT ANALYSIS 155

12.7.6 KEY STRATEGIES 156

12.8 AMBRY GENETICS 157

12.8.1 COMPANY OVERVIEW 157

12.8.2 FINANCIAL OVERVIEW 157

12.8.3 PRODUCTS/SERVICES OFFERED 157

12.8.4 KEY DEVELOPMENTS 157

12.8.5 SWOT ANALYSIS 158

12.8.6 KEY STRATEGIES 158

12.9 MACROGEN, INC. 159

12.9.1 COMPANY OVERVIEW 159

12.9.2 FINANCIAL OVERVIEW 159

12.9.3 PRODUCTS/SERVICES OFFERED 159

12.9.4 KEY DEVELOPMENTS 159

12.9.5 SWOT ANALYSIS 160

12.9.6 KEY STRATEGIES 160

12.10 INTEGRAGEN SA 161

12.10.1 COMPANY OVERVIEW 161

12.10.2 FINANCIAL OVERVIEW 161

12.10.3 PRODUCTS/SERVICES OFFERED 161

12.10.4 KEY DEVELOPMENTS 162

12.10.5 SWOT ANALYSIS 162

12.10.6 KEY STRATEGIES 162

13 APPENDIX

13.1 REFERENCES 163

13.2 RELATED REPORTS 164

14 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 19

TABLE 2 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT 2023-2032 (USD MILLION) 39

TABLE 3 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 39

TABLE 4 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY REGION 2023-2032 (USD MILLION) 39

TABLE 5 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS, BY REGION 2023-2032 (USD MILLION) 40

TABLE 6 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR LIBRARY PREPARATION, BY REGION 2023-2032 (USD MILLION) 40

TABLE 7 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR TARGET ENRICHMENT, BY REGION 2023-2032 (USD MILLION) 41

TABLE 8 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCER, BY REGION 2023-2032 (USD MILLION) 41

TABLE 9 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 42

TABLE 10 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY REGION 2023-2032 (USD MILLION) 42

TABLE 11 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCING SERVICES, BY REGION 2023-2032 (USD MILLION) 42

TABLE 12 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DATA ANALYSIS (BIOINFORMATICS), BY REGION 2023-2032 (USD MILLION) 43

TABLE 13 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER SERVICES, BY REGION 2023-2032 (USD MILLION) 43

TABLE 14 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 45

TABLE 15 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR SEQUENCING BY SYNTHESIS (SBS), BY REGION 2023-2032 (USD MILLION) 45

TABLE 16 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR ION SEMICONDUCTOR SEQUENCING, BY REGION 2023-2032 (USD MILLION) 46

TABLE 17 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER TECHNOLOGYS, BY REGION 2023-2032 (USD MILLION) 46

TABLE 18 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 2023-2032 (USD MILLION) 48

TABLE 19 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 48

TABLE 20 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY REGION 2023-2032 (USD MILLION) 49

TABLE 21 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR CANCER DIAGNOSTICS, BY REGION 2023-2032 (USD MILLION) 49

TABLE 22 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MONOGENIC (MENDELIAN) DISORDERS, BY REGION 2023-2032 (USD MILLION) 50

TABLE 23 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MONOGENIC TYPES OF DIABETES, BY REGION 2023-2032 (USD MILLION) 50

TABLE 24 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR MOVEMENT DISORDERS, BY REGION 2023-2032 (USD MILLION) 51

TABLE 25 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR HIV, BY REGION 2023-2032 (USD MILLION) 51

TABLE 26 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER DIAGNOSTICS, BY REGION 2023-2032 (USD MILLION) 52

TABLE 27 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION 2023-2032 (USD MILLION) 52

TABLE 28 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION 2023-2032 (USD MILLION) 53

TABLE 29 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER APPLICATIONS, BY REGION 2023-2032 (USD MILLION) 53

TABLE 30 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER 2023-2032 (USD MILLION) 55

TABLE 31 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR RESEARCH CENTERS AND GOVERNMENT INSTITUTES, BY REGION 2023-2032 (USD MILLION) 55

TABLE 32 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR HOSPITALS AND DIAGNOSTICS CENTERS, BY REGION 2023-2032 (USD MILLION) 56

TABLE 33 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION 2023-2032 (USD MILLION) 56

TABLE 34 GLOBAL WHOLE EXOME SEQUENCING MARKET, FOR OTHER ENS USERS, BY REGION 2023-2032 (USD MILLION) 57

TABLE 35 GLOBAL: WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 36 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 60

TABLE 37 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60

TABLE 38 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 61

TABLE 39 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 61

TABLE 40 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 61

TABLE 41 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 42 AMERICAS: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 62

TABLE 43 AMERICAS: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 63

TABLE 44 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 45 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 64

TABLE 46 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 64

TABLE 47 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 64

TABLE 48 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 65

TABLE 49 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 50 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 65

TABLE 51 NORTH AMERICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 52 US: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 66

TABLE 53 US: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 66

TABLE 54 US: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 67

TABLE 55 US: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 67

TABLE 56 US: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 57 US: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 68

TABLE 58 US: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 68

TABLE 59 CANADA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 69

TABLE 60 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 69

TABLE 61 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 69

TABLE 62 CANADA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 70

TABLE 63 CANADA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 64 CANADA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 70

TABLE 65 CANADA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 66 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 71

TABLE 67 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 71

TABLE 68 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 72

TABLE 69 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 72

TABLE 70 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 71 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 73

TABLE 72 LATIN AMERICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 73 EUROPE WHOLE EXOME SEQUENCING MARKET, BY REGION 2023-2032 (USD MILLION) 74

TABLE 74 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74

TABLE 75 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 75

TABLE 76 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 75

TABLE 77 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75

TABLE 78 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 79 EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 76

TABLE 80 EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 81 WESTERN EUROPE WHOLE EXOME SEQUENCING MARKET, BY COUNTRY 2023-2032 (USD MILLION) 77

TABLE 82 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77

TABLE 83 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 78

TABLE 84 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 78

TABLE 85 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78

TABLE 86 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 87 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 79

TABLE 88 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 80

TABLE 89 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

TABLE 90 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 80

TABLE 91 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 81

TABLE 92 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81

TABLE 93 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 94 GERMANY: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 82

TABLE 95 GERMANY: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 82

TABLE 96 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 83

TABLE 97 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 83

TABLE 98 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 83

TABLE 99 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84

TABLE 100 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84

TABLE 101 FRANCE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 84

TABLE 102 FRANCE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 85

TABLE 103 UK: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

TABLE 104 UK: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 85

TABLE 105 UK: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 86

TABLE 106 UK: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

TABLE 107 UK: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 108 UK: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 87

TABLE 109 UK: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 87

TABLE 110 ITALY: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88

TABLE 111 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 88

TABLE 112 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 88

TABLE 113 ITALY: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 89

TABLE 114 ITALY: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 115 ITALY: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 89

TABLE 116 ITALY: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 90

TABLE 117 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90

TABLE 118 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 90

TABLE 119 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 91

TABLE 120 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 91

TABLE 121 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 122 SPAIN: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 92

TABLE 123 SPAIN: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 92

TABLE 124 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93

TABLE 125 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 93

TABLE 126 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 93

TABLE 127 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94

TABLE 128 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 94

TABLE 129 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 94

TABLE 130 REST OF WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 95

TABLE 131 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 95

TABLE 132 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 95

TABLE 133 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 96

TABLE 134 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96

TABLE 135 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 136 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 97

TABLE 137 EASTERN EUROPE: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 97

TABLE 138 ASIA-PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98

TABLE 139 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99

TABLE 140 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 99

TABLE 141 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 99

TABLE 142 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 100

TABLE 143 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100

TABLE 144 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 100

TABLE 145 ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 146 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101

TABLE 147 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 101

TABLE 148 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 102

TABLE 149 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 102

TABLE 150 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 151 JAPAN: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 103

TABLE 152 JAPAN: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 153 CHINA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

TABLE 154 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 104

TABLE 155 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 104

TABLE 156 CHINA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105

TABLE 157 CHINA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 158 CHINA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 105

TABLE 159 CHINA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 106

TABLE 160 INDIA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106

TABLE 161 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 106

TABLE 162 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 107

TABLE 163 INDIA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 107

TABLE 164 INDIA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107

TABLE 165 INDIA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 108

TABLE 166 INDIA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 108

TABLE 167 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109

TABLE 168 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 109

TABLE 169 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 109

TABLE 170 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 110

TABLE 171 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110

TABLE 172 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 110

TABLE 173 SOUTH KOREA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 111

TABLE 174 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111

TABLE 175 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 111

TABLE 176 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 112

TABLE 177 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 112

TABLE 178 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 179 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 113

TABLE 180 AUSTRALIA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 113

TABLE 181 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114

TABLE 182 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 114

TABLE 183 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 114

TABLE 184 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 115

TABLE 185 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 186 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 115

TABLE 187 REST OF ASIA PACIFIC: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 116

TABLE 188 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117

TABLE 189 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117

TABLE 190 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 118

TABLE 191 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 118

TABLE 192 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 118

TABLE 193 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 194 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 119

TABLE 195 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 120

TABLE 196 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120

TABLE 197 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 120

TABLE 198 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 121

TABLE 199 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 121

TABLE 200 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 201 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 122

TABLE 202 MIDDLE EAST: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 122

TABLE 203 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123

TABLE 204 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR KITS, BY TYPE 2023-2032 (USD MILLION) 123

TABLE 205 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR SERVICES, BY TYPE 2023-2032 (USD MILLION) 123

TABLE 206 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 124

TABLE 207 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124

TABLE 208 AFRICA: WHOLE EXOME SEQUENCING MARKET, FOR DIAGNOSTICS, BY TYPE 2023-2032 (USD MILLION) 124

TABLE 209 AFRICA: WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020–2027 (USD MILLION) 125

TABLE 210 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE WHOLE EXOME SEQUENCING MARKET 130

TABLE 211 COLLABORATIONS & PARTNERSHIPS: GLOBAL WHOLE EXOME SEQUENCING MARKET 130

TABLE 212 EXPANSIONS: GLOBAL WHOLE EXOME SEQUENCING MARKET 131

TABLE 213 ILLUMINA INC.: PRODUCTS/SERVICES OFFERED 135

TABLE 214 ILLUMINA INC.: KEY DEVELOPMENTS 135

TABLE 215 BGI: PRODUCTS/SERVICES OFFERED 138

TABLE 216 BGI: KEY DEVELOPMENTS 139

TABLE 217 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 141

TABLE 218 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS 141

TABLE 219 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED 145

TABLE 220 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS 145

TABLE 221 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 148

TABLE 222 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 148

TABLE 223 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 151

TABLE 224 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 152

TABLE 225 GENEWIZ: PRODUCTS/SERVICES OFFERED 154

TABLE 226 GENEWIZ: KEY DEVELOPMENTS 155

TABLE 227 AMBRY GENETICS: PRODUCTS/SERVICES OFFERED 157

TABLE 228 MACROGEN, INC.: PRODUCTS/SERVICES OFFERED 159

TABLE 229 INTEGRAGEN SA: PRODUCTS/SERVICES OFFERED 161

15 LIST OF FIGURES

FIGURE 1 GLOBAL WHOLE EXOME SEQUENCING MARKET STRUCTURE 20

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL WHOLE EXOME SEQUENCING MARKET 29

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL WHOLE EXOME SEQUENCING MARKET 34

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL WHOLE EXOME SEQUENCING MARKET 36

FIGURE 6 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT 2019 & 2027 (USD MILLION) 38

FIGURE 7 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY 2019 & 2027 (USD MILLION) 44

FIGURE 8 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 2019 & 2027 (USD MILLION) 47

FIGURE 9 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER 2019 & 2027 (USD MILLION) 54

FIGURE 10 GLOBAL WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION) 59

FIGURE 11 AMERICAS: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 60

FIGURE 12 NORTH AMERICAS: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 63

FIGURE 13 EUROPE: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 74

FIGURE 14 WESTERN EUROPE: WHOLE EXOME SEQUENCING MARKET SHARE, BY REGION, 2019 (%) 77

FIGURE 15 ASIA-PACIFIC: WHOLE EXOME SEQUENCING MARKET SHARE, BY COUNTRY, 2019 (%) 98

FIGURE 16 MIDDLE EAST & AFRICA: WHOLE EXOME SEQUENCING MARKET SHARE, BY COUNTRY, 20209 (%) 117

FIGURE 17 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL WHOLE EXOME SEQUENCING MARKET 127

FIGURE 18 GLOBAL WHOLE EXOME SEQUENCING MARKET, MARKET SHARE ANALYSIS (% SHARE) 128

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS IN THE GLOBAL WHOLE EXOME SEQUENCING MARKET 129

FIGURE 20 SALES AND OPERATING PROFIT MARGIN, 2019 131

FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE, 2019 132

FIGURE 22 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT 134

FIGURE 23 ILLUMINA INC.: SWOT ANALYSIS 136

FIGURE 24 BGI: FINANCIAL OVERVIEW SNAPSHOT 138

FIGURE 25 BGI: SWOT ANALYSIS 139

FIGURE 26 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 140

FIGURE 27 EUROFINS SCIENTIFIC: SWOT ANALYSIS 142

FIGURE 28 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 144

FIGURE 29 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 146

FIGURE 30 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW 147

FIGURE 31 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 149

FIGURE 32 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW 151

FIGURE 33 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 152

FIGURE 34 GENEWIZ: FINANCIAL OVERVIEW SNAPSHOT 154

FIGURE 35 GENEWIZ: SWOT ANALYSIS 155

FIGURE 36 AMBRY GENETICS: SWOT ANALYSIS 158

FIGURE 37 MACROGEN, INC.: SWOT ANALYSIS 160

FIGURE 38 INTEGRAGEN SA: FINANCIAL OVERVIEW SNAPSHOT 161

FIGURE 39 INTEGRAGEN SA: SWOT ANALYSIS 162